Discover why uniQure N.V. (NASDAQ:QURE) is one of the top 24 stocks skyrocketing, with a remarkable 258% jump in Q4 2024. The gene therapy leader shows strong growth potential, backed by revenue increase and favorable Wall Street outlook.